IEG Policy is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House spending bill provides funding for FDA to act on CBD foods, supplements

Amendment aims to expedite agency's effort to find federal regulatory path

This article is powered by Food Chemical News

The FDA budget bill for FY 2020 pending in the House includes language directing the agency to expedite its effort to approve use of CBD in foods and dietary supplements.

Advertisement

Related Content

CBD offers opportunity for reform in FDA food and dietary supplements oversight
Hemp industry keen for FDA to act quickly on CBD
Congress will not wait for FDA to offer fix for CBD edibles, legal expert predicts

Topics

What to read next

UsernamePublicRestriction

Register

PL220664

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel